scispace - formally typeset
M

Mark Gerstein

Researcher at Yale University

Publications -  802
Citations -  172183

Mark Gerstein is an academic researcher from Yale University. The author has contributed to research in topics: Genome & Gene. The author has an hindex of 168, co-authored 751 publications receiving 149578 citations. Previous affiliations of Mark Gerstein include Rutgers University & Structural Genomics Consortium.

Papers
More filters
Proceedings ArticleDOI

GersteinLab at MEDIQA-Chat 2023: Clinical Note Summarization from Doctor-Patient Conversations through Fine-tuning and In-context Learning

TL;DR: This paper proposed a few-shot in-context learning (ICL) approach to the MEDIQA-2023 Dialogue2Note shared task, which achieved excellent results in terms of ROUGE-1 F1, BERTScore F1 (deberta-xlarge-mnli), and BLEURT, with scores of 0.4011, 0.7058, and 0.5421, respectively.
Journal ArticleDOI

STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.

TL;DR: In this article, the authors identified a 16-gene signature for LKB1 loss of function through mutational and non-mutational mechanisms and applied this genetic signature to TCGA lung adenocarcinoma samples and discovered a novel association between LK1 loss and widespread DNA demethylation.
Journal ArticleDOI

GRAM: A GeneRAlized Model to Predict the Molecular Effect of a Non-Coding Variant in a Cell-Type Specific Manner

TL;DR: This work coupled multiple genomic predictors to build GRAM, a GeneRAlized Model, to predict a well-defined experimental target: the expression-modulating effect of a non-coding variant on its associated gene, in a transferable, cell-specific manner.
Posted ContentDOI

Illuminating links between cis-regulators and trans-acting variants in the human prefrontal cortex

TL;DR: In this paper, the authors conduct a genome-wide survey of trans-eQTLs in the dorsolateral prefrontal cortex (DLPFC) by leveraging the large datasets from the PsychENCODE consortium.
Journal ArticleDOI

Dynamic quality control machinery that operates across compartmental borders mediates the degradation of mammalian nuclear membrane proteins

TL;DR: In this paper , the authors employ a short-lived Lamin B receptor disease variant as a model substrate in a genetic screen to uncover key elements of nuclear envelope (NE) protein turnover.